Pyxis Oncology CEO Buys 690K Shares at $0 – Signaling Confidence and Future Growth
Pyxis Oncology’s CEO buys 690k shares at $0.00, a sign of confidence as the company targets ADC breakthroughs, regulatory milestones, and potential upside for investors.
4 minutes to read